The Coalition for Epidemic Preparedness Innovations (CEPI) U.S. announced collaboration this week with Georgetown University through a cooperative academic and research agreement, focusing on training potential for future students and scientists.
“It’s exciting to collaborate with CEPI U.S. to explore additional ways our faculty can contribute to and advance the important global health mission of reducing the burden of infectious diseases,” Edward B. Healton, executive vice president for health sciences and co-chair of Georgetown University’s global health initiative, said. “Focusing on vaccines is good for global health security, but it’s especially good and important for people.”
The partnership is a natural fit for two organizations that are close geographically and have already seen overlap in membership. The director of Georgetown’s Center for Medical Product Access, Safety and Stewardship is a volunteer of CEPI’s regulatory working group and was one of its original developers. Internship, fellowship and postdoctoral opportunities for Georgetown’s undergraduate and graduate students are expected to come from the new arrangement.
CEPI was designed last year as a global coalition for the financing and development of new vaccines to fight infectious disease epidemics. It is headquartered in Norway.